Drug Regulatory Information | Announcement of the National Medical Products Administration on the Issuance of Work Procedures for the Review and Approval of Conditional Marketing Applications for Drug
2026/04/27
Attachment 1: Work Procedure for Review and Approval of Conditional Approval Application for Drug Marketing
Attachment 2: Policy Interpretation
- Pre：Shandong Xinbo invites Dr. Yuan Shoujun to give an academic lecture on "Belt and Road Model: Breaking the Industry Pain Points of Multi drug Joint Evaluation and Supporting Drug Interaction Evaluation
- Next：Drug Regulatory Information | Notice on Publicly Soliciting Opinions on the "Technical Guidelines for Pharmaceutical Research and Evaluation of Mesenchymal Stem Cell Products (Draft for Comments)"
